Redeye: W5 Solutions - Improving order outlook
Redeye updates on W5 following its Q1-results which came in slightly below our forecasts. Order intake was stable in Q1, and the company has seen an improvement during Q2 which supports our outlook for a stronger H2 2024. Still, we lower our near-term growth assumptions and our 2024-26E EBITDA estimates are down 9-12%.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/